儿茶素对慢性阻塞性肺疾病大鼠气道重塑和Nrf2/HO-1通路的影响OA
Effect of catechin on airway remodeling and Nrf2/HO-1 pathway of rats with chronic obstructive pulmonary disease
目的:探讨儿茶素(Cat)对慢性阻塞性肺疾病(COPD)大鼠气道重塑及 Nrf2/HO-1 通路的影响.方法:采用烟熏联合气道注射脂多糖法成功制备 COPD 模型大鼠共75 只,随机分为 COPD 组,Cat-L、Cat-M、Cat-H 组,Cat-H+ML385 组,每组 15 只;以不接受烟熏、正常的 15 只大鼠为对照组.Cat-L、Cat-M、Cat-H 组分别灌胃 0.7、1.4、2.8 mg/kg 的 Cat,Cat-H+ML385 组灌胃2.8 mg/kg Cat 并且腹腔注射 30 mg/kg 的 Nrf2 抑制剂 ML385,对照组、COPD 组给予生理盐水,每日给药1 次,连续4 周.末次给药后,检测大鼠肺功能(n=15);HE 染色观察肺组织学表现,测量支气管壁厚度及平滑肌厚度,免疫组化 SP 法检测肺组织中转化生长因子 1(TGF-β1)、α-平滑肌肌动蛋白(α-SMA)的表达(n=5);采用相应试剂盒检测肺泡灌洗液(BALF)中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶组织抑制剂-2(TIMP-2)水平(n=5),以及肺组织中超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)水平(n=5);Western blot法检测肺组织中 Nrf2、HO-1 蛋白的表达(n=5).结果:与对照组比较,COPD 组肺组织病理损伤明显,大量炎症细胞浸润;炎症评分达(3.20±0.30),支气管壁厚度,平滑肌厚度,气道阻力(RI),BALF 中 TNF-α、IL-6、MMP-2、MMP-9 浓度,肺组织中 MDA 及 TGF-β1、α-SMA 表达水平均升高;呼气峰值流速(PEF)、动态顺应性(Cydn),BALF 中TIMP-2 浓度,肺组织中 SOD、GSH-Px 及 Nrf2、HO-1 表达水平降低(P<0.05).与 COPD 组比较,3 个 Cat 组肺组织病理损伤减轻,炎症评分、支气管壁厚度、平滑肌厚度,RI,BALF 中 TNF-α、IL-6、MMP-2、MMP-9 浓度,肺组织中MDA 及TGF-β1、α-SMA 表达水平均降低;PEF、Cydn,BALF 中TIMP-2 浓度,肺组织中SOD、GSH-Px 及Nrf2、HO-1 表达水平升高(P<0.05),且呈剂量依赖性(P<0.05).与 Cat-H 组比较,Cat-H+ML385 组肺组织病理损伤加重,各项指标逆向改变(P<0.05).结论:儿茶素可能通过激活 Nrf2/HO-1 通路,抑制气道炎症与氧化应激反应,改善COPD 大鼠的气道重塑.
Aim:To explore the effect of catechin(Cat)on airway remodeling and nuclear factor E2 related factor 2/heme oxygenase-1(Nrf2/HO-1)pathway in rats with chronic obstructive pulmonary disease(COPD).Methods:A total of 75 COPD model rats were successfully established using a combination of smoke exposure and airway lipopolysaccharide in-jection,and were randomly allocated into COPD group,Cat-L,Cat-M,and Cat-H groups,and Cat-H+ML385 group,with 15 rats in each group.Fifteen rats without smoke exposure served as the control group.Cat-L,Cat-M,and Cat-H groups received Cat at doses of 0.7,1.4,and 2.8 mg/kg by gavage,respectively;the Cat-H+ML385 group received oral administration of 2.8 mg/kg Cat along with intraperitoneal injection of 30 mg/kg of ML385(Nrf2 inhibitor);the control group and COPD group were administered normal saline,once daily for 4 consecutive weeks.After the final administration,pulmonary function was assessed(n=15);HE staining was performed to observe pulmonary histopathological changes,and bronchial wall thick-ness as well as smooth muscle thickness were measured,immunohistochemical SP assay was used to detect the expression of transforming growth factor-1(TGF-β1)and α-smooth muscle actin(α-SMA)in lung tissue(n=5);corresponding kits were used to determine the levels of tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),matrix metalloproteinase-2(MMP-2),matrix metalloproteinase-9(MMP-9),and matrix metalloproteinase tissue inhibitor-2(TIMP-2)in bronchoalveolar lav-age fluid(BALF)(n=5),the levels of SOD,malondialdehyde(MDA),and glutathione peroxidase(GSH-Px)in lung tissue were measured(n=5);Western blot was employed to quantify the expression of Nrf2 and HO-1 proteins in lung tissue(n=5).Results:Compared with the control group,COPD group exhibited significant pathological damage in lung tissue with ex-tensive inflammatory cell infiltration,and the inflammatory scores were(3.20±0.30);bronchial wall thickness,smooth muscle thickness,airway resistance(RI),TNF-α,IL-6,MMP-2,and MMP-9 concentrations in BALF,MDA,as well as TGF-β1 and α-SMA expression in lung tissue increased;peak expiratory flow rate(PEF),dynamic compliance(Cydn),TIMP-2 in BALF,SOD and GSH-Px in lung tissue as well as Nrf2 and HO-1 expression decreased(P<0.05).Compared with the COPD group,the 3 CaT groups demonstrated reduced pathological damage in lung tissue with lower inflammatory scores,bronchial wall thickness,smooth muscle thickness,RI,TNF-α,IL-6,MMP-2,and MMP-9 in BALF,lower MDA levels in lung tissue,and decreased TGF-β1 and α-SMA expression;concurrently,increased PEF,Cydn,TIMP-2 level in BALF,and elevated SOD,GSH-Px levels,and Nrf2 and HO-1 expression(P<0.05),exhibiting dose-dependent effects(P<0.05).In contrast to the Cat-H group,the Cat-H+ML385 group showed aggravated pathological damage in lung tissue,with opposite changes in all parameters(P<0.05).Conclusion:Cat may activate the Nrf2/HO-1 pathway to inhibit airway inflammation and oxidative stress,and improve airway remodeling in COPD rats.
唐雪焱;张卓然
利川市人民医院呼吸与危重症医学科 湖北利川 445400锦州医科大学研究生培养基地(黄石市第二医院)呼吸与危重症医学科 湖北 黄石 435000
医药卫生
儿茶素Nrf2/HO-1通路慢性阻塞性肺疾病气道重塑大鼠
catechinNrf2/HO-1 pathwaychronic obstructive pulmonary diseaseairway remodelingrat
《郑州大学学报(医学版)》 2026 (4)
11-16,6
湖北省卫生健康科研项目(WJ2023F093)
评论